Literature DB >> 9635624

Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis.

R K Dhiman1, A K Seth, S Jain, Y K Chawla, J B Dilawari.   

Abstract

Viral hepatitis is the commonest cause of fulminant hepatic failure (FHF) in developing countries. We evaluated the early indicators of prognosis in these patients by multivariate analysis. The records of 204 consecutive patients with acute liver failure admitted with hepatic encephalopathy over five years were studied. The etiology of these patients included virus related in 186 (91.1%), drug induced in 15 (7.4%), Wilson's disease in one (0.5%), acute Budd-Chiari syndrome in one (0.5%), and malignant infiltration in one (0.5%). Patients with FHF complicating viral hepatitis were analyzed by univariate and multivariate analysis. These patients were further subclassified depending upon the interval between the onset of jaundice and the onset of encephalopathy into hyperacute (HALF; interval 0-7 days), acute (ALF; interval 8-28 days) and subacute liver failure (SALF; interval 4-12 weeks). Sixty (32.3%) patients with viral hepatitis survived. Univariate analysis showed that the interval between onset of encephalopathy and onset of jaundice, grade of encephalopathy, raised intracranial pressure, prothrombin time, and serum bilirubin levels on admission were related to outcome in these patients. Multivariate logistic regression analysis showed that the presence of raised intracranial pressure at the time of admission, prothrombin time >100 sec on admission, age (>50 yr), and onset of encephalopathy seven days after onset of jaundice were associated with poor prognosis. Forty seven (37.0%) of 129 patients with HALF survived compared with 9 (22.5%) of 40 with ALF and 4 (21.1%) of 19 with SALF (P = NS). Raised intracranial pressure was more frequent in patients with HALF (48.8%) than in patients with ALF (32.5%) and SALF (15.8%; P = 0.01), while clinically detectable ascites was more frequent in patients with SALF (78.9%) compared with HALF (19.7%) and ALF (37.5%; P < 0.0001). The factors adversely affecting the outcome in our patients with FHF complicating viral hepatitis include presence of overt clinical features of raised ICP at the time of hospitalization, prothrombin time (>100 sec) on admission, age (>50 yr), and onset of encephalopathy seven days after onset of jaundice.

Entities:  

Mesh:

Year:  1998        PMID: 9635624     DOI: 10.1023/a:1018876328561

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Portal hypertension in acute liver failure.

Authors:  M Navasa; J C Garcia-Pagán; J Bosch; J R Riera; R Bañares; A Mas; M Bruguera; J Rodés
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 2.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

3.  Should we redefine acute liver failure?

Authors:  S K Acharya; S Dasarathy; B N Tandon
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321

4.  Classifying acute liver failure.

Authors:  J Bernuau; J P Benhamou
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

5.  The prevalence and prognostic significance of spontaneous bacterial peritonitis in severe acute hepatitis with ascites.

Authors:  C M Chu; K W Chiu; Y F Liaw
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

Review 6.  Fulminant hepatic failure: summary of a workshop.

Authors:  J H Hoofnagle; R L Carithers; C Shapiro; N Ascher
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

7.  Acute sporadic non-A, non-B hepatitis in India.

Authors:  M S Khuroo; W Duermeyer; S A Zargar; M A Ahanger; M A Shah
Journal:  Am J Epidemiol       Date:  1983-09       Impact factor: 4.897

8.  Etiological role of hepatitis E virus in sporadic fulminant hepatitis.

Authors:  S K Nanda; K Yalcinkaya; A K Panigrahi; S K Acharya; S Jameel; S K Panda
Journal:  J Med Virol       Date:  1994-02       Impact factor: 2.327

9.  Acute liver failure. Experience with 145 patients.

Authors:  B N Tandon; Y K Joshi; M Tandon
Journal:  J Clin Gastroenterol       Date:  1986-12       Impact factor: 3.062

10.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

View more
  30 in total

1.  Portal hemodynamics in fulminant hepatic failure as assessed by duplex Doppler ultrasonography.

Authors:  Y Chawla; A Sreedharan; R K Dhiman; S Jain; S Suri
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Brain preservation during orthotopic liver transplantation in a patient with acute liver failure and severe elevation of intracranial pressure.

Authors:  Alexandru Gottlieb; Kathrine R DeBoer
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

3.  The study of efficacy of lamivudine in patients with severe acute hepatitis B.

Authors:  Jian-Wu Yu; Li-Jie Sun; Yong-Hua Zhao; Peng Kang; Shu-Chen Li
Journal:  Dig Dis Sci       Date:  2009-12-03       Impact factor: 3.199

4.  Outcome of acute liver failure in the elderly.

Authors:  Frank V Schiødt; Raymond T Chung; Michael L Schilsky; J Eileen Hay; Erik Christensen; William M Lee
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

5.  Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group.

Authors:  Robert H Squires; Benjamin L Shneider; John Bucuvalas; Estella Alonso; Ronald J Sokol; Michael R Narkewicz; Anil Dhawan; Philip Rosenthal; Norberto Rodriguez-Baez; Karen F Murray; Simon Horslen; Martin G Martin; M James Lopez; Humberto Soriano; Brendan M McGuire; Maureen M Jonas; Nada Yazigi; Ross W Shepherd; Kathleen Schwarz; Steven Lobritto; Daniel W Thomas; Joel E Lavine; Saul Karpen; Vicky Ng; Deirdre Kelly; Nancy Simonds; Linda S Hynan
Journal:  J Pediatr       Date:  2006-05       Impact factor: 4.406

Review 6.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

7.  Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure.

Authors:  Kazuhiro Kotoh; Munechika Enjoji; Makoto Nakamuta; Tsuyoshi Yoshimoto; Motoyuki Kohjima; Shusuke Morizono; Shinsaku Yamashita; Yuki Horikawa; Kengo Yoshimitsu; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

9.  Aetiology and outcome of acute liver failure.

Authors:  Ravi Marudanayagam; Vivekanandan Shanmugam; Bridget Gunson; Darius F Mirza; David Mayer; John Buckels; Simon R Bramhall
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

10.  Natural course of fulminant hepatic failure: the scenario in Bangladesh and the differences from the west.

Authors:  Shahinul Alam; Golam Azam; Golam Mustafa; Abul Kalam Azad; Izazul Haque; Shakil Gani; Nooruddin Ahmad; Khorshed Alam; Mobin Khan
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.